Area of interest: Life science
-
Alba Health raises 2.5 MUSD
(Stockholm, develops a digital platform combining microbiome analysis and AI to support child gut health): Has raised 2.5 MEUR in a funding round from Exceptional Ventures, Voima Ventures, Noaber, Petteri Lahtela, Bust with members David Klagsbrun and Madeleine Johansson Palmberg, alongside Unconventional Ventures with members Thea Messel and Nora Bavey. “We at Alba help parents…
-
SeaPattern raises 8 MSEK
(Linköping, enhances electricity generation in hydropower plants): Has raised 8 MSEK in a funding round from Norrsken Launcher with members Erik Engellau-Nilsson, Anna Fredrixon, Fredrik Jung Abbou, and founding member Ash Pournouri. “We will first establish a strong presence in Sweden, Norway, and Finland, and then expand into Europe. After that, the plan is to…
-
Echandia raises 220 MSEK
(Stockholm, develops battery systems for ferries, navy vessels, and other maritime applications): Has raised 220 MSEK in a funding round from Alantra’s Klimat fund, Industrifonden with member Peter Wolpert, SEB Greentech VC, and Japan’s EEI. “Our revenues grew fourfold in 2024 compared to 2023, and with our current sales pipeline, we expect our revenues to…
-
Recarber raises 60 MSEK
(Stockholm, a platform for capturing and storing carbon dioxide – and selling credits to large corporations): Has raised 60 MSEK in a funding round from Luminar Ventures with members Louise Hagen and Magnus Bergman, Spintop Ventures with member Peter Carlsson, and Course Corrected with members Christine Ahlstrand and Kerstin Cooley. “We hope to bring our first project to an investment decision early next year. It will likely involve either a combined heat and power plant or…
-
Gesynta Pharma raises 26.5 MEUR
(Stockholm, is developing a drug candidate for the treatment of endometriosis): Has raised 26.5 MEUR in a funding round led by Innovestor Life Science, with participation from Hadean Ventures, Linc, Foreground Capital, Catalyze Capital, Stephen Industries, Amboy Street Ventures, and Industrifonden with member Peter Wolpert. The funding will support a Phase II clinical trial in Europe.
-
Vaja raises 4.35 MSEK
(Stockholm, wind-adaptive technology for solar parks): Has raised 4.5 MSEK in a funding round from Node.vc with founding member John Elvesjö and members Daniela Sjunnesson, Rebecca Sjödin, Mårten Skogö, Henrik Tellving, and Andy Johnston. “We have a humble ambition to revolutionize the global solar park market,” comments Henrik Eskilsson.
-
AnaCardio raises 19 MUSD
(Stockholm, develops novel drugs to treat heart failure): Has raised 19 MUSD in a funding round from Novo Holdings, Pureos Bioventures, Sound Bioventures, Flerie, Fredrik andAnn-Helene Ljungström alongside Industrifonden with member Peter Wolpert. “We now have the data and funding to accelerate the further clinical development of our first-in-class inotrope to improve the lives of patients with heart failure,” comments…
-
Cellevate raises 3.2 MEUR
(Lund, develops the next generation of cell culture systems designed to revolutionize biomanufacturing): Has raised 3.2 MEUR in a funding round from the EIC and Industrifonden with member Peter Wolpert. “This renewed investment is dedicated to achieving the most important milestone for Cellevate: the successful global launch, commercialization, and sales of the first nanofiber-based microcarriers in upstream bioprocessing,” comments Laura Chirica.
-
Amferia raises 1.2 MEUR
(Gothenburg, medical devices that kill bacteria, even resistant bacteria, without harming the body): Has raised 1.2 MEUR in a funding round from new and existing investors, including member Björn Engström. “Antibiotics are absolutely essential. Without them, we cannot survive. Our technology is not about replacing antibiotics but helping healthcare professionals use them more effectively,” comments Anand Rajasekharan,…
